{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:47:25Z","timestamp":1781513245222,"version":"3.54.1"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T00:00:00Z","timestamp":1703548800000},"content-version":"am","delay-in-days":300,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.neuropharm.2022.109387","type":"journal-article","created":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T22:08:57Z","timestamp":1671746937000},"page":"109387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Atorvastatin differentially regulates the interactions of cocaine and amphetamine with dopamine transporters"],"prefix":"10.1016","volume":"225","author":[{"given":"Shiyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna I.","family":"Neel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen L.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiguo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara R.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allyn C.","family":"Howlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5644-4386","authenticated-orcid":false,"given":"Rong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2022.109387_bib1","doi-asserted-by":"crossref","first-page":"10484","DOI":"10.1021\/bi700429z","article-title":"Membrane mobility and microdomain association of the dopamine transporter studied with fluorescence correlation spectroscopy and fluorescence recovery after photobleaching","volume":"46","author":"Adkins","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2022.109387_bib2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.atherosclerosis.2019.09.022","article-title":"Cholesterol transfer at the plasma membrane","volume":"290","author":"Axmann","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.neuropharm.2022.109387_bib3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.mcn.2008.06.011","article-title":"Dopamine transporter endocytic determinants: carboxy terminal residues critical for basal and PKC-stimulated internalization","volume":"39","author":"Boudanova","year":"2008","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109387_bib4","doi-asserted-by":"crossref","first-page":"19066","DOI":"10.1074\/jbc.M117.787002","article-title":"Dopamine transporter phosphorylation site threonine 53 is stimulated by amphetamines and regulates dopamine transport, efflux, and cocaine analog binding","volume":"292","author":"Challasivakanaka","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2022.109387_bib5","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/jnc.12229","article-title":"Protein kinase Cbeta is a modulator of the dopamine D2 autoreceptor-activated trafficking of the dopamine transporter","volume":"125","author":"Chen","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2022.109387_bib6","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1124\/jpet.108.147959","article-title":"Protein kinase Cbeta is a critical regulator of dopamine transporter trafficking and regulates the behavioral response to amphetamine in mice","volume":"328","author":"Chen","year":"2009","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2022.109387_bib7","doi-asserted-by":"crossref","first-page":"18755","DOI":"10.1074\/jbc.M413895200","article-title":"Statins cause intracellular accumulation of amyloid precursor protein, beta-secretase-cleaved fragments, and amyloid beta-peptide via an isoprenoid-dependent mechanism","volume":"280","author":"Cole","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2022.109387_bib8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.59566\/IJBS.2009.5411","article-title":"Statins inhibit the proliferation and induce cell death of human papilloma virus positive and negative cervical cancer cells","volume":"5","author":"Crescencio","year":"2009","journal-title":"Int. J. Biomed. Sci."},{"key":"10.1016\/j.neuropharm.2022.109387_bib9","doi-asserted-by":"crossref","first-page":"7231","DOI":"10.2147\/CMAR.S212643","article-title":"Statins induce cell apoptosis through a modulation of AKT\/FOXO1 pathway in prostate cancer cells","volume":"11","author":"Deng","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.neuropharm.2022.109387_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114349","article-title":"Serotonin transporter regulation by cholesterol-independent lipid signaling","volume":"183","author":"Deveau","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109387_bib11","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1194\/jlr.R400004-JLR200","article-title":"Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal","volume":"45","author":"Dietschy","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.neuropharm.2022.109387_bib12","first-page":"103","article-title":"Suppression of Idol expression is an additional mechanism underlying statin-induced up-regulation of hepatic LDL receptor expression","volume":"27","author":"Dong","year":"2011","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.neuropharm.2022.109387_bib13","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.neuron.2006.06.028","article-title":"Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport","volume":"51","author":"Fog","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2022.109387_bib14","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/j.1471-4159.2008.05262.x","article-title":"Phorbol ester induced trafficking-independent regulation and enhanced phosphorylation of the dopamine transporter associated with membrane rafts and cholesterol","volume":"105","author":"Foster","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2022.109387_bib15","doi-asserted-by":"crossref","first-page":"29702","DOI":"10.1074\/jbc.M112.367706","article-title":"Dopamine transporter phosphorylation site threonine 53 regulates substrate reuptake and amphetamine-stimulated efflux","volume":"287","author":"Foster","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2022.109387_bib16","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1124\/mol.114.091926","article-title":"An N-terminal threonine mutation produces an efflux-favorable, sodium-primed conformation of the human dopamine transporter","volume":"86","author":"Fraser","year":"2014","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109387_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10652","article-title":"Mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in Drosophila brain","volume":"7","author":"Freyberg","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2022.109387_bib18","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1523\/JNEUROSCI.5386-08.2009","article-title":"Dopamine and amphetamine rapidly increase dopamine transporter trafficking to the surface: live-cell imaging using total internal reflection fluorescence microscopy","volume":"29","author":"Furman","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109387_bib19","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.1074\/jbc.RA118.006223","article-title":"Cholesterol depletion inhibits Na(+),K(+)-ATPase activity in a near-native membrane environment","volume":"294","author":"Garcia","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2022.109387_bib20","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1476-511X-12-126","article-title":"The effect of simvastatin on lipid droplets accumulation in human embryonic kidney cells and pancreatic cancer cells","volume":"12","author":"Gbelcova","year":"2013","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.neuropharm.2022.109387_bib21","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1124\/mol.110.069039","article-title":"Site-directed mutations near transmembrane domain 1 alter conformation and function of norepinephrine and dopamine transporters","volume":"79","author":"Guptaroy","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109387_bib22","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1124\/mol.108.048744","article-title":"A juxtamembrane mutation in the N terminus of the dopamine transporter induces preference for an inward-facing conformation","volume":"75","author":"Guptaroy","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109387_bib23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0165-6147(97)01147-4","article-title":"Hydrophilicity\/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors","volume":"19","author":"Hamelin","year":"1998","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2022.109387_bib24","doi-asserted-by":"crossref","first-page":"32616","DOI":"10.1074\/jbc.M110.150565","article-title":"Membrane cholesterol modulates the outward facing conformation of the dopamine transporter and alters cocaine binding","volume":"285","author":"Hong","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2022.109387_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuint.2018.08.015","article-title":"Model systems for analysis of dopamine transporter function and regulation","volume":"123","author":"Hovde","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2022.109387_bib26","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.1059344","article-title":"Structural mechanism for statin inhibition of HMG-CoA reductase","volume":"292","author":"Istvan","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2022.109387_bib27","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/jnc.12007","article-title":"Importance of cholesterol in dopamine transporter function","volume":"123","author":"Jones","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2022.109387_bib28","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nsmb.2816","article-title":"Conformational dynamics of ligand-dependent alternating access in LeuT","volume":"21","author":"Kazmier","year":"2014","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2022.109387_bib29","doi-asserted-by":"crossref","first-page":"E78","DOI":"10.1371\/journal.pbio.0020078","article-title":"N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux","volume":"2","author":"Khoshbouei","year":"2004","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neuropharm.2022.109387_bib30","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0006-2952(02)01654-4","article-title":"Statin effects on cholesterol micro-domains in brain plasma membranes","volume":"65","author":"Kirsch","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109387_bib31","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1161\/hy1101.093103","article-title":"3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors upregulate inducible NO synthase expression and activity in vascular smooth muscle cells","volume":"38","author":"Kolyada","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.neuropharm.2022.109387_bib32","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature10737","article-title":"X-ray structures of LeuT in substrate-free outward-open and apo inward-open states","volume":"481","author":"Krishnamurthy","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2022.109387_bib33","doi-asserted-by":"crossref","first-page":"22168","DOI":"10.1074\/jbc.M301845200","article-title":"The dopamine transporter constitutively internalizes and recycles in a protein kinase C-regulated manner in stably transfected PC12 cell lines","volume":"278","author":"Loder","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2022.109387_bib34","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/nsmb.2894","article-title":"A mechanism for intracellular release of Na+ by neurotransmitter\/sodium symporters","volume":"21","author":"Malinauskaite","year":"2014","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2022.109387_bib35","doi-asserted-by":"crossref","first-page":"20607","DOI":"10.3390\/ijms151120607","article-title":"Molecular mechanisms underlying the effects of statins in the central nervous system","volume":"15","author":"McFarland","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2022.109387_bib36","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.bbamem.2019.01.001","article-title":"Membrane cholesterol depletion reduces downstream signaling activity of the adenosine A2A receptor","volume":"1861","author":"McGraw","year":"2019","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.neuropharm.2022.109387_bib37","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.40009","article-title":"The sterol-responsive RNF145 E3 ubiquitin ligase mediates the degradation of HMG-CoA reductase together with gp78 and Hrd1","volume":"7","author":"Menzies","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.neuropharm.2022.109387_bib38","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.neuropharm.2018.01.039","article-title":"Membrane cholesterol removal and replenishment affect rat and monkey brain monoamine transporters","volume":"133","author":"Morissette","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109387_bib39","doi-asserted-by":"crossref","first-page":"22037","DOI":"10.1074\/jbc.273.34.22037","article-title":"Degradation of HMG-CoA reductase in vitro. Cleavage in the membrane domain by a membrane-bound cysteine protease","volume":"273","author":"Moriyama","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2022.109387_bib40","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1006\/abbi.2000.2209","article-title":"3-hydroxy-3-methylglutaryl coenzyme A reductase is sterol-dependently cleaved by cathepsin L-type cysteine protease in the isolated endoplasmic reticulum","volume":"386","author":"Moriyama","year":"2001","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.neuropharm.2022.109387_bib41","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s11606-014-3115-3","article-title":"Do statins impair cognition? A systematic review and meta-analysis of randomized controlled trials","volume":"30","author":"Ott","year":"2015","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.neuropharm.2022.109387_bib42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nature12533","article-title":"X-ray structure of dopamine transporter elucidates antidepressant mechanism","volume":"503","author":"Penmatsa","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2022.109387_bib43","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1007\/s00018-003-3018-7","article-title":"Cholesterol homeostasis and function in neurons of the central nervous system","volume":"60","author":"Pfrieger","year":"2003","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2022.109387_bib44","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/j.1552-4604.1996.tb04242.x","article-title":"Tolerance and pharmacokinetics of single-dose atorvastatin, a potent inhibitor of HMG-CoA reductase, in healthy subjects","volume":"36","author":"Posvar","year":"1996","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109387_bib45","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00054556","article-title":"Cholesterol biosynthesis and metabolism","volume":"6","author":"Russell","year":"1992","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.neuropharm.2022.109387_bib46","unstructured":"Sahebzamani, F., Munro, C., Marroquin, O., Diamond, D., Keller, E., Kip, K., 2014. Examination of the FDA warning for statins and cognitive dysfunction. J. Pharmacovigilance. 2, 141 Here is the link to the paper: https:\/\/www.walshmedicalmedia.com\/open-access\/examination-of-the-fda-warning-for-statins-and-cognitive-dysfunction-2329-6887-2-141.pdf."},{"key":"10.1016\/j.neuropharm.2022.109387_bib47","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.1038\/s41598-017-04769-4","article-title":"Differential membrane dipolar orientation induced by acute and chronic cholesterol depletion","volume":"7","author":"Sarkar","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2022.109387_bib48","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1472-8206.2004.00299.x","article-title":"Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update","volume":"19","author":"Schachter","year":"2005","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109387_bib49","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0006-2952(01)00790-0","article-title":"Effect of atorvastatin, simvastatin, and lovastatin on the metabolism of cholesterol and triacylglycerides in HepG2 cells","volume":"62","author":"Scharnagl","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109387_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002265","article-title":"Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: a longitudinal, population-based prospective cohort study","volume":"14","author":"Schilling","year":"2017","journal-title":"PLoS Med."},{"key":"10.1016\/j.neuropharm.2022.109387_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11060340","article-title":"The impact of simvastatin on lipidomic markers of cardiovascular risk in human liver cells is secondary to the modulation of intracellular cholesterol","volume":"11","author":"Schooneveldt","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.neuropharm.2022.109387_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1000905","article-title":"Modeling and dynamics of the inward-facing state of a Na+\/Cl- dependent neurotransmitter transporter homologue","volume":"6","author":"Shaikh","year":"2010","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.neuropharm.2022.109387_bib53","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.molcel.2008.05.008","article-title":"The mechanism of a neurotransmitter:sodium symporter--inward release of Na+ and substrate is triggered by substrate in a second binding site","volume":"30","author":"Shi","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neuropharm.2022.109387_bib54","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-0854.2005.00259.x","article-title":"Constitutive and protein kinase C-induced internalization of the dopamine transporter is mediated by a clathrin-dependent mechanism","volume":"6","author":"Sorkina","year":"2005","journal-title":"Traffic"},{"key":"10.1016\/j.neuropharm.2022.109387_bib55","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1096\/fj.03-0372fje","article-title":"Membrane cholesterol interferes with neuronal apoptosis induced by soluble oligomers but not fibrils of amyloid-beta peptide","volume":"18","author":"Sponne","year":"2004","journal-title":"Faseb. J. : official publication of the Federation of American Societies for Experimental Biology"},{"key":"10.1016\/j.neuropharm.2022.109387_bib56","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.pneurobio.2005.04.003","article-title":"Mechanisms of neurotransmitter release by amphetamines: a review","volume":"75","author":"Sulzer","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2022.109387_bib57","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.tips.2013.07.005","article-title":"Mechanisms of dopamine transporter regulation in normal and disease states","volume":"34","author":"Vaughan","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2022.109387_bib58","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.physbeh.2016.02.029","article-title":"The effect of prolonged simvastatin application on serotonin uptake, membrane microviscosity and behavioral changes in the animal model","volume":"158","author":"Vevera","year":"2016","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2022.109387_bib59","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0090-9556(25)07595-6","article-title":"Metabolic disposition studies on simvastatin, a cholesterol-lowering prodrug","volume":"18","author":"Vickers","year":"1990","journal-title":"Drug Metabol. Dispos.: the biological fate of chemicals"},{"key":"10.1016\/j.neuropharm.2022.109387_bib60","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1592\/phco.23.7.871.32720","article-title":"Statin-associated memory loss: analysis of 60 case reports and review of the literature","volume":"23","author":"Wagstaff","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.neuropharm.2022.109387_bib61","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nature14431","article-title":"Neurotransmitter and psychostimulant recognition by the dopamine transporter","volume":"521","author":"Wang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2022.109387_bib62","doi-asserted-by":"crossref","first-page":"7593","DOI":"10.1038\/srep07593","article-title":"Statin-induced mevalonate pathway inhibition attenuates the growth of mesenchymal-like cancer cells that lack functional E-cadherin mediated cell cohesion","volume":"4","author":"Warita","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2022.109387_bib63","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejcnurse.2010.08.008","article-title":"The effects of statins on mood: a review of the literature","volume":"11","author":"While","year":"2012","journal-title":"Eur. J. Cardiovasc. Nurs."},{"key":"10.1016\/j.neuropharm.2022.109387_bib64","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1096\/fj.02-0818fje","article-title":"Transport of plasma membrane-derived cholesterol and the function of Niemann-Pick C1 Protein","volume":"17","author":"Wiegand","year":"2003","journal-title":"Faseb. J. : official publication of the Federation of American Societies for Experimental Biology"},{"key":"10.1016\/j.neuropharm.2022.109387_bib65","doi-asserted-by":"crossref","first-page":"15480","DOI":"10.1073\/pnas.1512957112","article-title":"Ack1 is a dopamine transporter endocytic brake that rescues a trafficking-dysregulated ADHD coding variant","volume":"112","author":"Wu","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2022.109387_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005907","article-title":"A direct interaction of cholesterol with the dopamine transporter prevents its out-to-inward transition","volume":"14","author":"Zeppelin","year":"2018","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.neuropharm.2022.109387_bib67","first-page":"1919","article-title":"Effects of various doses of atorvastatin on vascular endothelial cell apoptosis and autophagy in vitro","volume":"19","author":"Zhao","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.neuropharm.2022.109387_bib68","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.bbamem.2007.03.026","article-title":"Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies","volume":"1768","author":"Zidovetzki","year":"2007","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822004464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822004464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:23:33Z","timestamp":1758439413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390822004464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":68,"alternative-id":["S0028390822004464"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109387","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atorvastatin differentially regulates the interactions of cocaine and amphetamine with dopamine transporters","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109387","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109387"}}